ELVN
Enliven Therapeutics, Inc. · Healthcare · Market cap $3.1B
Insiders sold $11.8M net in the last 90 days ·4 sellers, 0 buyers· 7 of 8 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 21, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$76.9M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Latest filing
Oct 21, 2026
Hohl Benjamin
Enliven Therapeutics, Inc. (ELVN) has 41 SEC Form 4 filings (103 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Oct 21, 2026.
Inside the rolling window, 10 insiders at Enliven Therapeutics, Inc. reported no open-market purchases and 38 open-market sales totaling $76.9M. The most active filer is CHIEF MEDICAL OFFICER Collins Helen Louise with 12 filings. Insiders have net sold $65.6M over the trailing 6 months. The most recent open-market filing is a sale of 6,018 shares by CHIEF FINANCIAL OFFICER Hohl Benjamin, dated Oct 19, 2026, worth $232K.
- Industry:Biotechnology
- CEO:Richard A. Fair
- Employees:61
- HQ:Boulder, CO, US
- IPO:2020-03-12
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CHIEF FINANCIAL OFFICER | Sale | 6,018 | $232K | Oct 21 | +0.3% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $192K | Oct 21 | +0.3% | SEC ↗ | |
Garland J. ScottFirst filing | Director | Sale | 13,000 | $607K | Oct 5 | -7.8% | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $252K | Sep 21 | -14.2% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 6,018 | $303K | Sep 21 | -14.2% | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $293K | Aug 19 | -29.4% | SEC ↗ | |
| CHIEF FINANCIAL OFFICER | Sale | 6,018 | $353K | Aug 19 | — | SEC ↗ | |
Derynck Mika KFirst filing | Director | Sale | 158,795 | $9.6M | Aug 7 | — | SEC ↗ |
| CHIEF FINANCIAL OFFICER | Sale | 6,018 | $317K | Jul 21 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $263K | Jul 21 | — | SEC ↗ | |
| Director | Sale | 10,000 | $505K | Jul 8 | — | SEC ↗ | |
| 10% Owner | Sale | 860,123 | $39.0M | Jun 24 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $219K | Jun 22 | — | SEC ↗ | |
Hohl BenjaminFirst in 3 months | CHIEF FINANCIAL OFFICER | Sale | 6,018 | $264K | Jun 22 | — | SEC ↗ |
| 10% Owner | Sale | 281,408 | $12.7M | Jun 17 | — | SEC ↗ | |
Kunkel Lori AnneFirst filing | Director | Sale | 10,000 | $345K | Jun 9 | — | SEC ↗ |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $199K | May 20 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $238K | Apr 21 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 40,000 | $1.4M | Mar 27 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 5,000 | $139K | Mar 19 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 29,871 | $897K | Mar 11 | — | SEC ↗ | |
| CHIEF MEDICAL OFFICER | Sale | 10,129 | $306K | Mar 11 | — | SEC ↗ | |
Hohl BenjaminFirst filing | CHIEF FINANCIAL OFFICER | Sale | 10,000 | $296K | Mar 10 | — | SEC ↗ |
Collins Helen LouiseFirst filing | CHIEF MEDICAL OFFICER | Sale | 45,000 | $1.2M | Feb 19 | — | SEC ↗ |
| Director | Sale | 1,230 | $32K | Feb 19 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does ELVN have?
Enliven Therapeutics, Inc. (ELVN) has 41 SEC Form 4 filings (103 transaction rows) in the rolling 365-day window, disclosed by 10 distinct insiders. Most recent filing: Oct 21, 2026.
When was the most recent SEC Form 4 filing for ELVN?
The most recent Form 4 filing for ELVN on Tracefour is dated Oct 21, 2026.
Who is the most active insider at ELVN?
The most active SEC Form 4 filer at ELVN in the rolling window is CHIEF MEDICAL OFFICER Collins Helen Louise, with 12 filings.
What is the net insider flow at ELVN over the last 6 months?
Over the trailing 180 days, insiders at ELVN have net sold $65.6M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ELVN in the current window?
Inside the rolling window, insiders at ELVN bought $0 and sold $76.9M based on SEC Form 4 filings.
Can I get alerts for ELVN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Enliven Therapeutics, Inc. (ELVN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Enliven Therapeutics, Inc. is in the Healthcare sector.